FDA Orange Book

Generic for Tekturna

Tekturna contains aliskiren. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

Yes. The generic name for Tekturna is aliskiren. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 2 of the 3 Tekturna products the Orange Book lists.

Run it in Rivvi

Map Tekturna and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Tekturna products in the Orange Book

Tekturna products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
capsule, pellet, oralEQ 37.5MG BASEDiscontinuedNone0None
tablet, oralEQ 150MG BASEMarketed (Rx)AB1AB
tablet, oralEQ 300MG BASEMarketed (Rx)AB1AB

NDA 210709, 021985, held by NODEN PHARMA DAC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic aliskiren

Approved generic versions of Tekturna
CompanyANDATE codeApprovedStrengths
PH HEALTH LTD206665AB (A-rated, therapeutically equivalent)March 22, 2019EQ 150MG BASE, EQ 300MG BASE

Tekturna patents

Patents listed for Tekturna
PatentExpiresCoversUse codeNDA
8617595February 19, 2026Drug productNone021985
8617595*PEDAugust 19, 2026Method of useNone021985

Tekturna NDC codes

Questions

Is there a generic for Tekturna?

Yes. The generic name for Tekturna is aliskiren. 1 company holds an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB. Generics match 2 of the 3 Tekturna products the Orange Book lists.

What is the generic name for Tekturna?

The active ingredient in Tekturna is aliskiren, per the FDA Orange Book.

When does the Tekturna patent expire?

The last patent listed for Tekturna in the Orange Book expires August 19, 2026. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Tekturna and Aliskiren

Try it on your own data today.

Free to start. Most teams are using it the same day.